Skip to content
AnalystLens

Texas Instruments 8-K Report, Financial Results (Oct 22, 2024)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed October 22, 2024
Period End
October 22, 2024
Security
TXN
In the record · 2016–202610-K1110-Q338-K110

TXN filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 110 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Dec ’21Dec ’21
  2. Leadership change8-K · Jun ’26Jun ’26

Summary

Summary of the 8-K filed October 22, 2024. Cited figures are marked; the original filing is the authoritative source.

Texas Instruments reported third-quarter 2024 revenue of $4.15 billiona, down 8% year over year but up 9% sequentially, with net income of $1.36 billion (down 20%) and diluted EPS of $1.47 (down 21%).

Operating profit fell 18% to $1.55 billionb. Management said Industrial continued to decline sequentially while all other end markets grew. The Analog segment revenue fell 4% year over year, while Embedded Processing revenue dropped 27% and its operating profit fell 58%.

EPS included a 3-cent benefit from items not in the original guidance. Cash generation remained strong on a trailing-twelve-month basis. Cash flow from operations was $6.24 billionc (down 4%), and capital expenditures were $4.78 billion (down 2%), leaving free cash flow of $1.47 billion (down 11%).

Free cash flow margin improved slightly to 9.3% of revenue. Capital spending is elevated as TI builds out its 300mm production capacity, and the company's cash flow from operations for the period included a $532 milliond benefit from the CHIPS Act investment tax credit. Total TTM cash returned to shareholders was $5.19 billion, mostly dividends, and quarterly buybacks fell 58% to $318 million.

Total debt rose to about $13.9 billion from $11.2 billion a year earlier. For the fourth quarter, TI guided to revenue of $3.70 billion to $4.00 billion and EPS of $1.07 to $1.29, with an expected effective tax rate of about 13%. The guidance midpoint implies a further sequential revenue decline, so the near-term trajectory remains the key investor question, alongside whether the heavy investment cycle eventually converts into stronger free cash flow.

Key Highlights

  1. Q3 2024 revenue of $4.15B, down 8% YoY and up 9% sequentially; net income of $1.36B (down 20%) and diluted EPS of $1.47 (down 21%)
  2. Operating profit of $1.55B, down 18% YoY; gross profit margin of about 60% versus about 62% a year earlier
  3. Embedded Processing revenue fell 27% YoY to $653M with operating profit down 58%, the weakest segment; Analog revenue fell 4% to $3.22B
  4. TTM free cash flow of $1.47B (down 11%) as capex of $4.78B remained elevated for 300mm capacity expansion; FCF margin of 9.3% of revenue
  5. Q4 2024 guidance: revenue of $3.70B-$4.00B and EPS of $1.07-$1.29, with an effective tax rate of about 13%
  6. Total TTM shareholder returns of $5.19B, including $4.74B in dividends; quarterly buybacks fell 58% to $318M
  7. Total debt rose to about $13.9B from $11.2B a year earlier, and the company received a $220M CHIPS Act investment tax credit benefit in the quarter

Frequently Asked Questions

  1. Why did TI's revenue and earnings decline year over year?

    Revenue fell 8% to $4.15B, driven mainly by weakness in industrial markets and a 27% drop in Embedded Processing revenue. Lower revenue, higher R&D and interest expense, and a smaller operating profit pushed net income down 20% and EPS down 21%.

  2. Is TI generating enough cash to fund its dividend and investments?

    On a trailing-twelve-month basis, cash flow from operations of $6.24B covered capex of $4.78B and left $1.47B of free cash flow, which is less than the $4.74B paid in dividends. TI funded the gap with cash on hand and new borrowing, and debt has risen to about $13.9B. Investors should watch whether free cash flow recovers as the capacity build-out matures.

  3. What does the Q4 2024 outlook imply?

    The guidance of $3.70B to $4.00B in revenue, at a midpoint of $3.85B, implies a further sequential decline from Q3's $4.15B. EPS guidance of $1.07 to $1.29 is also lower than the $1.47 reported in Q3, suggesting continued near-term pressure.

  4. How much of the cash flow benefit came from government incentives?

    The CHIPS and Science Act investment tax credit reduced income taxes payable by $220M in Q3 and $532M over the trailing twelve months. This helped operating cash flow, so underlying free cash flow generation is somewhat weaker than the reported figures suggest.

  5. Why did share repurchases decline so sharply?

    Stock repurchases fell 58% on a trailing-twelve-month basis to $318M in Q3 from $1.08B in the prior-year period. The filing does not explain the reduction, but it is consistent with management prioritizing dividends and capital spending while cash generation is under pressure.